Axicabtagene ciloleucel
Gilead,Daiichi Sankyo
[' lena', 'lenalidomide']
 by then a bispecific would be approved &amp; outside of a trial i'd give a bispecific or lenalidomide-based regimen based on the data we have currently available.
Assistant Professor of Medicine @UWCarbone | Lymphoma, Cellular Immunotherapies & BMT | Runner ????? Mother of 2 amazing. silly kids